BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37691350)

  • 1. Single-cell RNA sequencing captures patient-level heterogeneity and associated molecular phenotypes in breast cancer pleural effusions.
    Whitfield HJ; Berthelet J; Mangiola S; Bell C; Anderson RL; Pal B; Yeo B; Papenfuss AT; Merino D; Davis MJ
    Clin Transl Med; 2023 Sep; 13(9):e1356. PubMed ID: 37691350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of pro-angiogenic factors and establishment of tolerance in malignant pleural effusions.
    Lieser EA; Croghan GA; Nevala WK; Bradshaw MJ; Markovic SN; Mansfield AS
    Lung Cancer; 2013 Oct; 82(1):63-8. PubMed ID: 23948549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploratory pilot study to characterize the immune landscapes of malignant pleural effusions and their corresponding primary tumors from patients with breast carcinoma and lung adenocarcinoma.
    Laberiano-Fernandez C; Gan Q; Wang SM; Tamegnon A; Wistuba I; Yoon E; Roy-Chowdhuri S; Parra ER
    J Am Soc Cytopathol; 2024; 13(3):161-173. PubMed ID: 38519275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancer.
    Wu YY; Hsu YL; Huang YC; Su YC; Wu KL; Chang CY; Ong CT; Lai JC; Shen TY; Lee TH; Hung JY; Tsai YM
    Theranostics; 2023; 13(13):4412-4429. PubMed ID: 37649596
    [No Abstract]   [Full Text] [Related]  

  • 5. Deconvolution of malignant pleural effusions immune landscape unravels a novel macrophage signature associated with worse clinical outcome in lung adenocarcinoma patients.
    Bruschini S; Pallocca M; Sperandio E; D'Ambrosio L; Ascenzi F; De Vitis C; Salvati V; Esposito A; Di Martino S; De Nicola F; Paolini F; Fattore L; Alessandrini G; Facciolo F; Foddai ML; Bassi M; Venuta F; D'Ascanio M; Ricci A; D' Andrilli A; Napoli C; Aurisicchio L; Fanciulli M; Rendina EA; Ciliberto G; Mancini R
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35584864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity.
    Roscilli G; De Vitis C; Ferrara FF; Noto A; Cherubini E; Ricci A; Mariotta S; Giarnieri E; Giovagnoli MR; Torrisi MR; Bergantino F; Costantini S; Fenizia F; Lambiase M; Aurisicchio L; Normanno N; Ciliberto G; Mancini R
    J Transl Med; 2016 Feb; 14():61. PubMed ID: 26928703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migrated T lymphocytes into malignant pleural effusions: an indicator of good prognosis in lung adenocarcinoma patients.
    Nieto JC; Zamora C; Porcel JM; Mulet M; Pajares V; Muñoz-Fernandez AM; Calvo N; Espinosa I; Pascual-García M; Bielsa S; Vidal S
    Sci Rep; 2019 Feb; 9(1):2996. PubMed ID: 30816121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sestrin-2 is significantly increased in malignant pleural effusions due to lung cancer and is potentially secreted by pleural mesothelial cells.
    Tsilioni I; Filippidis AS; Kerenidi T; Budanov AV; Zarogiannis SG; Gourgoulianis KI
    Clin Biochem; 2016 Jun; 49(9):726-728. PubMed ID: 26874199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the diagnosis and management of malignant pleural effusions.
    Heffner JE; Klein JS
    Mayo Clin Proc; 2008 Feb; 83(2):235-50. PubMed ID: 18241636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma.
    Meiller C; Montagne F; Hirsch TZ; Caruso S; de Wolf J; Bayard Q; Assié JB; Meunier L; Blum Y; Quetel L; Gibault L; Pintilie E; Badoual C; Humez S; Galateau-Sallé F; Copin MC; Letouzé E; Scherpereel A; Zucman-Rossi J; Le Pimpec-Barthes F; Jaurand MC; Jean D
    Genome Med; 2021 Jul; 13(1):113. PubMed ID: 34261524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Profiling of Malignant Pleural Effusions with Next Generation Sequencing (NGS): Evidence that Supports Its Role in Cancer Management.
    Grigoriadou GΙ; Esagian SM; Ryu HS; Nikas IP
    J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33139621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer ratio and other new parameters for differentiation between malignant and nonmalignant pleural effusions.
    Korczyński P; Mierzejewski M; Krenke R; Safianowska A; Light RW
    Pol Arch Intern Med; 2018 Jun; 128(6):354-361. PubMed ID: 29968696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant pleural effusion supernatants are substitutes for metastatic pleural tumor tissues in EGFR mutation test in patients with advanced lung adenocarcinoma.
    Liu D; Lu Y; Hu Z; Wu N; Nie X; Xia Y; Han Y; Li Q; Zhu G; Bai C
    PLoS One; 2014; 9(2):e89946. PubMed ID: 24587142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superiority and clinical significance of Lunx mRNA in the diagnosis of malignant pleural effusion caused by pulmonary carcinoma.
    Tang Y; Xu L
    J Exp Clin Cancer Res; 2013 Jun; 32(1):37. PubMed ID: 23759037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions.
    Park JE; Do YW; Lee DH; Lee SY; Lim JK; Choi SH; Seo HW; Yoo SS; Lee SY; Cha SI; Park JY; Lee J; Kim CH
    Am J Med Sci; 2020 Sep; 360(3):236-242. PubMed ID: 32423747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors.
    Yang J; Lee OJ; Son SM; Woo CG; Jeong Y; Yang Y; Kwon J; Lee KH; Han HS
    Cancer Res Treat; 2018 Jul; 50(3):908-916. PubMed ID: 28934846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Malignant Pleural Effusion Resident CD8
    Dhupar R; Okusanya OT; Eisenberg SH; Monaco SE; Ruffin AT; Liu D; Luketich JD; Kammula US; Bruno TC; Lotze MT; Soloff AC
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients.
    Zhang Z; Ji W; Huang J; Zhang Y; Zhou Y; Zhang J; Dong Y; Yuan T; Yang Q; Ding X; Tang L; Li H; Yin J; Wang Y; Ji T; Fei J; Zhang B; Chen P; Hu H
    Clin Transl Med; 2022 Nov; 12(11):e1072. PubMed ID: 36305631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic profiling of putative breast cancer stem cells from malignant pleural effusions.
    Tiran V; Stanzer S; Heitzer E; Meilinger M; Rossmann C; Lax S; Tsybrovskyy O; Dandachi N; Balic M
    PLoS One; 2017; 12(4):e0175223. PubMed ID: 28423035
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.